Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall.

TitlePharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall.
Publication TypeJournal Article
Year of Publication2003
AuthorsMcGough, JJ, Biederman J, Greenhill LL, McCracken JT, Spencer TJ, Posner K, Wigal S, Gornbein J, Tulloch S, Swanson JM
JournalJournal of the American Academy of Child and Adolescent Psychiatry
Volume42
Issue6
Pagination684-91
Date Published2003 Jun
ISSN0890-8567
KeywordsAmphetamines, Attention Deficit Disorder with Hyperactivity, Central Nervous System Stimulants, Child, Cluster Analysis, Cross-Over Studies, Delayed-Action Preparations, Double-Blind Method, Female, Humans, Male
Abstract

To assess the pharmacokinetic (PK) properties of a single daily dose of Adderall (mixed amphetamine salts) and the extended-release formulation, SLI381 (ADDERALL XR), in pediatric attention-deficit/hyperactivity disorder (ADHD).

DOI10.1016/j.comppsych.2011.05.003
Alternate JournalJ Am Acad Child Adolesc Psychiatry